A Phase 1 Study to Evaluate the Adhesion, Pharmacokinetics (PK) and Safety of a Seven-Day Application of Donepezil Transdermal Delivery System (TDS) in Healthy Volunteers

Trial Profile

A Phase 1 Study to Evaluate the Adhesion, Pharmacokinetics (PK) and Safety of a Seven-Day Application of Donepezil Transdermal Delivery System (TDS) in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Donepezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Jan 2017 Status changed from recruiting to completed.
    • 11 Jan 2017 Planned number of patients changed from 48 to 86.
    • 26 Jul 2016 Oral sub-study group has been added to the treatment regimen and primary end point has been added to obtain PK profile as per Australian New Zealand Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top